Tuberculosis:グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

【英文タイトル】Tuberculosis Global Clinical Trials Review, H2, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Tuberculosis 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Tuberculosis 24
Subjects Recruited Over a Period of Time 28
Prominent Sponsors 29
Top Companies Participating in Tuberculosis Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
GlaxoSmithKline plc 33
Clinical Trial Overview of GlaxoSmithKline plc 33
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
Otsuka Pharmaceutical Co., Ltd. 35
Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd. 35
Janssen Infectious Diseases 36
Clinical Trial Overview of Janssen Infectious Diseases 36
Tibotec BVBA 37
Clinical Trial Overview of Tibotec BVBA 37
Alaeras, Inc 38
Clinical Trial Overview of Alaeras, Inc 38
Cadila Pharmaceuticals Ltd. 39
Clinical Trial Overview of Cadila Pharmaceuticals Ltd. 39
Vakzine Projekt Management GmbH 40
Clinical Trial Overview of Vakzine Projekt Management GmbH 40
Intercell AG 41
Clinical Trial Overview of Intercell AG 41
Johnson & Johnson 42
Clinical Trial Overview of Johnson & Johnson 42
Sequella, Inc. 43
Clinical Trial Overview of Sequella, Inc. 43
Sanofi 44
Clinical Trial Overview of Sanofi 44
AstraZeneca PLC 45
Clinical Trial Overview of AstraZeneca PLC 45
Silence Therapeutics plc 46
Clinical Trial Overview of Silence Therapeutics plc 46
Archivel Farma S.L. 47
Clinical Trial Overview of Archivel Farma S.L. 47
Otsuka Pharmaceutical Development & Commercialization, Inc. 48
Clinical Trial Overview of Otsuka Pharmaceutical Development & Commercialization, Inc. 48
AbbVie Inc. 49
Clinical Trial Overview of AbbVie Inc. 49
Interactive Research and Development 50
Clinical Trial Overview of Interactive Research and Development 50
World Health Advanced Technologies, Ltd. 51
Clinical Trial Overview of World Health Advanced Technologies, Ltd. 51
Clinical Trial Overview of Top Institutes / Government 52
The National Institute of Allergy and Infectious Diseases 52
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 52
University of Oxford 56
Clinical Trial Overview of University of Oxford 56
U.S. Centers for Disease Control and Prevention 58
Clinical Trial Overview of U.S. Centers for Disease Control and Prevention 58
University of Cape Town 60
Clinical Trial Overview of University of Cape Town 60
National Taiwan University Hospital 62
Clinical Trial Overview of National Taiwan University Hospital 62
National Heart, Lung, and Blood Institute 64
Clinical Trial Overview of National Heart, Lung, and Blood Institute 64
Statens Serum Institut 65
Clinical Trial Overview of Statens Serum Institut 65
Johns Hopkins University 66
Clinical Trial Overview of Johns Hopkins University 66
All India Institute of Medical Sciences 67
Clinical Trial Overview of All India Institute of Medical Sciences 67
Seoul National University Hospital 68
Clinical Trial Overview of Seoul National University Hospital 68
French National Agency for Research on AIDS and Viral Hepatitis 69
Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis 69
London School of Hygiene & Tropical Medicine 70
Clinical Trial Overview of London School of Hygiene & Tropical Medicine 70
Department of Health, South Africa 71
Clinical Trial Overview of Department of Health, South Africa 71
Global Alliance for TB Drug Development 72
Clinical Trial Overview of Global Alliance for TB Drug Development 72
Tuberculosis Research Centre 73
Clinical Trial Overview of Tuberculosis Research Centre 73
Assistance Publique – Hopitaux de Paris 74
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 74
Asan Medical Center 75
Clinical Trial Overview of Asan Medical Center 75
Aeras Global Tb Vaccine Foundation 76
Clinical Trial Overview of Aeras Global Tb Vaccine Foundation 76
University Medical Center Groningen 77
Clinical Trial Overview of University Medical Center Groningen 77
AIDS Clinical Trials Group 78
Clinical Trial Overview of AIDS Clinical Trials Group 78
Five Key Clinical Profiles 79
Appendix 111
Abbreviations 111
Definitions 111
Research Methodology 112
Secondary Research 112
About GlobalData 113
Contact Us 113
Disclaimer 113
Source 114


【レポート販売概要】

■ タイトル:Tuberculosis:グローバル臨床試験レビューH2, 2013
■ 英文:Tuberculosis Global Clinical Trials Review, H2, 2013
■ 発行日:2013年7月31日
■ 調査会社:GlobalData
■ 商品コード:GDATA403161598
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。